Author

@BlueDuckCap BlueDuckCap

Conviction special-situations PM dissecting under-covered small/mid-caps with disclosed positions

Original bottom-up special-situations and activist-angle res

trader score
-0.33
hit rate
35%
mean α
-0.23%
signals 14d
7

Grade = how their written analysis reads (A best). Trader score = how their last-20 timestamped calls performed vs SPY.

Their picks, scored

Across their last 20 scored bets: 35% hit rate, -0.23% mean alpha, trader score -0.33. Their last-14d mentions, direction-adjusted, have moved +1.3% since posting (mean over 3 mentions with price data).

Recent signals7receipts included
date (PT)tickerauthorsentwhat they saidsince thenreceipt
2026-10-16XGN@BlueDuckCap+0.70Buy XGN and STIM at current discounted prices. — Explicitly characterizes both stocks as on sale here.·
2026-10-16STIM@BlueDuckCap+0.70Buy XGN and STIM at current discounted prices. — Explicitly characterizes both stocks as on sale here.·
2026-10-14SNAP@BlueDuckCap+0.25Notes a record 189-day insider-sale gap and views continued absence of sales as potentially bullish.+3.9%
2026-10-13STLN@BlueDuckCap+0.70Expects fast specialty-pharma growth and praises STLN's execution and market-share gains.·
2026-10-08STLN@BlueDuckCap+0.65Calls the referenced development positive because it validates STLN's payer value proposition.·
2026-10-06SNAP@BlueDuckCap-0.15Credits Snap's products and shareholder posture but maintains that executive churn is high.+9.7%
2026-10-06SNAP@BlueDuckCap+0.45Argues dilution-funded investment in Specs is necessary and could create substantial long-term upside.+9.7%

Grade is our human read-worthiness rating; trader score is a rolling 20-bet hit-rate/alpha composite — different things, often disagreeing. “Since then” is direction-unaware in the table; the summary line above adjusts for which way they leaned.